Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Lithium citrate tetrahydrate (in reverse-micelle formulation)

EU orphan designation number: EU/3/09/706   
Active ingredient: Lithium citrate tetrahydrate (in reverse-micelle formulation)
Indication: Treatment of Huntington´s disease
Sponsor: Medesis Pharma
L’Orée des Mas, avenue du Golf, F-34670 Baillargues, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/02/2010 Centralised Orphan - Designation EMEA/OD/095/09 (2010)654 of 28/01/2010